DUBLIN–( COMPANY CORD)– The “Biologics Agreement Advancement and Production Company Market Projection to 2033” has actually been included in ResearchAndMarkets.com’s offering. The worldwide biologics agreement growth and production company (CDMO) market, valued at USD 19.22 billion in 2024, is predicted to expand at a compound yearly development price of 9.21%, getting to USD 42.32 billion by 2033. This growth is sustained by the enhancing need for targeted treatments to resolve persistent and unusual dis
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/biologics-cdmo-market-trends-and-investment-forecast-to-2033-features-analysis-of-lonza-group-catalent-pharma-solutions-samsung-biologics-and-other-key-industry-players-researchandmarkets-com/
